Facebook Twitter LinkedIn Google Plus RSS

Matinas BioPharma moves to Bedminster

By ,

Biopharmaceutical company Matinas BioPharma Holdings Inc. announced today it has established its corporate headquarters in Bedminster.

According to the announcement, the company, which recently closed a $15 million financing, is now positioned to begin advancing the development of omega-3 lead product candidate, MAT9001, for the treatment of severe hypertriglyceridemia and mixed dyslipidemia.

"We believe [establishing headquarters in New Jersey] strategically positions us very well to have access to great talent and the financial and pharmaceutical communities," Chief Executive Roelof Rongen said in a statement.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close